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Topic 41 – Biomarkers
0033
Can cardiac troponin I measurement help to predict recent coronary
occlusion in out-of-hospital cardiac arrest survivors?
Amina Asadi (1), Rachida Habbal (1), Nicolas Barber-Chamoux (2), Pas-
cal Motreff (2), Jean René Lusson (2)
(1) CHU Ibn Rochd, Cardiologie, Casablanca, Maroc – (2) CHU Gabriel
Montpied, Cardiologie, Clermont Ferrand, France
Background: Recent guidelines recommend the immediate performance of
a coronary angiography when an acute myocardial infarction is suspected as a
cause of out-of-hospital cardiac arrest. However, prehospital factors such as post
resuscitation electrocardiogram pattern or clinical features are poorly sensitive in
this setting. We searched to evaluate if a measurement of cardiac troponin I can
help to detect a recent coronary lesion in out-of-hospital cardiac arrest.
Methods: Between January 2012 and Juin 2013, 54 out-of-hospital cardiac
arrest survivors have been consecutively studied. An immediate coronary
angiography has been systematically performed. Blood cardiac troponin I
levels at admission were analyzed to assess the optimum cutoff for identifying
a recent coronary lesion, using ROC curves with the criterion of Youden.
Results: During coronary angiography, a coronary artery disease has been
detected in 36 of 54 patients (66%). The optimum cardiac troponin I threshold
was determined at 0,5μg/l
Significant coronary artery disease was observed in 76% of patients with
troponin I >0,5μg/l and in 12% of patients with troponin I < 0,5μg/l (p=0.001)
(sensitivity 97%, specificity 41%). 
Conclusion: In this cohort of out-of-hospital cardiac arrest patients, iso-
lated cardiac troponin I measurement is modestly predictive of a recent coro-
nary lesion. As a result and given the high benefit of percutaneous coronary
intervention for such patients, the dosage of cardiac troponin I at admission
could not help in the decision of early coronary angiography.
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Serum IF1 concentration as a predictor of mortality in coronary heart
disease patients
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Aim: The ecto-F1-ATPase/P2Y13 pathway plays a key role in reverse cho-
lesterol transport. Exogenous IF1, known as the natural mitochondrial specific
inhibitor of F1-ATPase activity, inhibits ecto-F1-ATPase activity and
decreases HDL-C uptake by hepatocytes. We previously found that IF1 is
present in human serum and is negatively associated with coronary heart dis-
ease (CHD). Here, we investigated the relationship between serum IF1 con-
centration and mortality in CHD patients.
Methods: Serum IF1 was measured in 624 CHD patients aged 45-74 from
the GENES (Genetique et ENvironement en Europe du Sud) study. After
9.1 years follow up, mortality rate was 24.5%. 
Results: Patients who had died were older at inclusion, were more often
treated for dyslipidemia or diabetes mellitus, had higher tobacco consumption,
CRP level but lower physical activity. Resting heart rate and the Gensini score
of CHD severity were higher while LVEF (Left Ventricular Ejection Fraction)
was decreased. They also had lower serum IF1 concentration (0.41 vs 0,44μg/ml,
p=0.03). In CHD patients, IF1 concentration was negatively associated with
triglycerides, Gensini score and resting heart rate and positively with physical
activity, HDL-C and LVEF. HDL-C was correlated with the Gensini score but
not with resting heart rate and LVEF. Serum IF1 in the two highest quartiles
(≥0,42μg/ml) was associated with significantly reduced mortality risk, even
after multivariate adjustments for classical cardiovascular risk factors and
Gensini score (HR=0.55, p=0.026 for the highest quartile). Significance was
lost after adjustment for LVEF (HR=0.72, p=0.23). 
Conclusion: High serum IF1 is predictor of reduced mortality in CHD
patients. This prognostic value remains significant whatever the value of
HDL-C and Gensini score, a marker of atheroma diffusion, but was lost after
adjustment for LVEF. Correlation between serum IF1 concentration and
LVEF might underlie the relationship between IF1 level and mortality.
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Preoperative Growth Differentiation Factor 15 (GDF15) as a novel
biomarker of acute kidney injury after cardiac bypass surgery
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Objective: Previously, we demonstrated that preoperative plasma GDF15
levels significantly improved the prognostic value of the EuroSCORE for
mortality after cardiac surgery. Despite the strong correlation between GDF15
and renal function, no data are available regarding the potential interest of pre-
operative GDF15 levels to improve the prediction of acute kidney injury
(AKI) after coronary artery bypass grafting (CABG).
Design: 134 patients operated on for CABG of whom 50 underwent off-
pump surgery at our university hospital were included in this prospective,
observational study. Exclusion criteria were age <18 years or >80 years, pre-
vious atrial fibrillation/flutter, previous severe renal failure (estimated glomer-
ular filtration rate (eGFR) <30ml/min), previous cardiac surgery, and
emergency surgery. AKI was defined according to KDIGO criteria. GDF15
levels in plasma were measured before induction and 12 hours after surgery.
Results: 42 patients developed postoperative AKI which had significantly
higher preoperative plasma GDF15 levels (OR=2.851; 95%CI=1.32-6.13,
p=0.008), higher preoperative serum creatinine levels (OR=1.025;
95%CI=1.003-1.05; p=0.026), and most often underwent cardiopulmonary
bypass (CPB) surgery (OR=2.67; 95%CI: 1.17-6.14, p=0.020). On ROC
curves, GDF15 was found to be the best preoperative biomarker to predict
AKI (AUC 0.83; CI 0.75-0.89), compared with eGFR (AUC 0.67; 95%CI
0.59-0.75 p=0.003) and NT-proBNP (AUC 0.62; CI 0.51-0.72 p<0.001).
GDF15 level was also significantly better than the EuroSCORE in predicting
AKI (AUC 0.62, 95%CI 0.54-0.70 p<0.001). The predictive model including
high blood pressure, diabetes, preoperative eGFR and CPB surgery was sig-
nificantly improved when preoperative GDF15 was added.
Conclusion: Preoperative GDF15 plasma levels are associated with post-
operative AKI in CABG patients. Preoperative GDF15 may improve preoper-
ative risk stratification and discrimination among candidates for surgery.
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Background: Post-operative atrial fibrillation (POAF) following cardiac
surgery has a high prevalence and is associated with considerable morbidity.
Aims: To assess the role of GDF-15, a member of the TGFβ superfamily,
as a potential new predictor of POAF after off-pump (OFP) and on-pump
(ONP) coronary artery bypass graft (CABG) surgery.
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